US FDA fags serious lapses at Dabur India plant in inspection report
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
US FDA fags serious lapses at Dabur India plant in inspection report
The US Food and Drug Administration has flagged compliance gaps at a Dabur India facility in Dadra and Nagar Haveli, citing data integrity issues, poor maintenance, and lapses in production records, along with possible contamination risks in storage and testing.
US FDA flags manufacturing and data integrity lapses at Dabur...
New Delhi, May 31 (IANS) The US Food and Drug Administration (FDA) has flagged serious manufacturing, maintenance and data integrity lapses at a Dabur India manufacturing facility in Dadra and Nagar Haveli, at a time when Indian pharmaceutical and healthcare product makers are facing increased scrutiny from US regulators over quality standards and manufacturing practices. […] The post US FDA flags manufacturing and data integrity lapses at Dabur…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
